Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
More countries suspend use of AstraZeneca vaccine over blood clot concerns | AI model predicts CVD, CAD
Wednesday, March 17, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

More countries suspend use of AstraZeneca vaccine due to potential blood clot risk

The World Health Organization and European Medicines Agency have both repeatedly indicated that this does not appear to be a significant issue, but the two organizations are studying the situation closely.

READ MORE >
Covid vaccine
Share on Twitter Share on Facebook Share on Linkedin

More countries suspend use of AstraZeneca vaccine due to potential blood clot risk

Share on Twitter Share on Facebook Share on Linkedin
Covid vaccine
The World Health Organization and European Medicines Agency have both repeatedly indicated that this does not appear to be a significant issue, but the two organizations are studying the situation closely.
READ MORE >

AI model predicts death from cardiovascular disease, coronary artery disease better than other advanced techniques

The analysis, published in JACC: Cardiovascular Imaging, included clinical data and non-contrast CT findings from more than 66,000 patients. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI model predicts death from cardiovascular disease, coronary artery disease better than other advanced techniques

Share on Twitter Share on Facebook Share on Linkedin
The analysis, published in JACC: Cardiovascular Imaging, included clinical data and non-contrast CT findings from more than 66,000 patients. 
READ MORE >

Beta-blocker use not associated with depression—but it may be tied to unusual dreams, insomnia

Overall, the study's authors found that depression was just as likely when patients took beta-blockers or a placebo.

READ MORE >
Sleepless
Share on Twitter Share on Facebook Share on Linkedin

Beta-blocker use not associated with depression—but it may be tied to unusual dreams, insomnia

Share on Twitter Share on Facebook Share on Linkedin
Sleepless
Overall, the study's authors found that depression was just as likely when patients took beta-blockers or a placebo.
READ MORE >

Featured Articles

Heart attacks more likely to be missed in women than men

When treating female patients, researchers explained, physicians are less likely to think there is potential for a heart attack.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Heart attacks more likely to be missed in women than men

Share on Twitter Share on Facebook Share on Linkedin
When treating female patients, researchers explained, physicians are less likely to think there is potential for a heart attack.
READ MORE >

Philips, American College of Cardiology collaborate to improve cardiovascular care

While Philips is offering its available resources in the fields of research and development, the ACC is sharing the knowledge and experience of its more than 50,000 members.

READ MORE >
Handshake
Share on Twitter Share on Facebook Share on Linkedin

Philips, American College of Cardiology collaborate to improve cardiovascular care

Share on Twitter Share on Facebook Share on Linkedin
Handshake
While Philips is offering its available resources in the fields of research and development, the ACC is sharing the knowledge and experience of its more than 50,000 members.
READ MORE >

New Jersey cardiologist faces up to 20 years in prison for illegally distributing Oxycodone

The 59-year-old cardiologist prescribed and distributed more than 8,000 Oxycodone pills. 

READ MORE >
A gavel and a stethoscope
Share on Twitter Share on Facebook Share on Linkedin

New Jersey cardiologist faces up to 20 years in prison for illegally distributing Oxycodone

Share on Twitter Share on Facebook Share on Linkedin
A gavel and a stethoscope
The 59-year-old cardiologist prescribed and distributed more than 8,000 Oxycodone pills. 
READ MORE >

From the Magazine

Better Together? An Integrated Market for Calcium-modification Strategies

Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. 

READ MORE >
 (OCT) intravascular images (bottom).
Share on Twitter Share on Facebook Share on Linkedin

Better Together? An Integrated Market for Calcium-modification Strategies

Share on Twitter Share on Facebook Share on Linkedin
 (OCT) intravascular images (bottom).
Rather than a binary choice—atherectomy or lithotripsy—the market for treating severely calcified lesions seems likely to evolve into a mixture of both technologies. 
READ MORE >

Succession Planning: Prepare Your Practice to Survive the Retirement Tsunami

Succession planning is about a practice’s top job, but it’s not *only* about the top job.

READ MORE >
succession_planning.png
Share on Twitter Share on Facebook Share on Linkedin

Succession Planning: Prepare Your Practice to Survive the Retirement Tsunami

Share on Twitter Share on Facebook Share on Linkedin
succession_planning.png
Succession planning is about a practice’s top job, but it’s not *only* about the top job.
READ MORE >

In Other News

Is COVID-focused AI ready for legal scrutiny?

Affronts against privacy and equality—real, perceived or ginned up—may fuel lawsuits by patients whose COVID care incorporated AI.

READ MORE >
Gavel
Share on Twitter Share on Facebook Share on Linkedin

Is COVID-focused AI ready for legal scrutiny?

Share on Twitter Share on Facebook Share on Linkedin
Gavel
Affronts against privacy and equality—real, perceived or ginned up—may fuel lawsuits by patients whose COVID care incorporated AI.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme